NMN and Collagen Production: Skin From the Inside

NMN and Collagen production might sound like an unlikely pairing, but the connection runs deeper than marketing claims. Your skin's structural integrity depends on collagen synthesis, and that process is extraordinarily energy-intensive — which is precisely where NAD+, the molecule NMN is designed to replenish, enters the picture. Understanding this link matters because collagen loss isn't just cosmetic; it reflects declining cellular energy capacity that accelerates with age.

The Evidence Base

Direct human trials examining NMN's effect on skin collagen are scarce. None of the published randomized controlled trials in humans were designed with dermal collagen as a primary endpoint. What we have instead are well-controlled studies measuring NMN's impact on NAD+ metabolism, muscle function, and systemic biomarkers — outcomes that inform, but do not prove, a skin-specific benefit.

Yoshino et al. (2021) conducted a randomized, placebo-controlled, crossover trial in 25 postmenopausal women with prediabetes. Participants received 250 mg NMN daily for 10 weeks. The primary outcome was muscle insulin sensitivity, which improved significantly. NAD+ metabolites in skeletal muscle increased, confirming target engagement. Skin collagen was not measured, but the trial established that oral NMN at this dose robustly raises tissue NAD+ in humans [Yoshino 2021].

Igarashi et al. (2022) extended this work in healthy older men, using doses of 250 mg and 500 mg NMN daily over 12 weeks. Both doses elevated blood NAD+ levels. The 500 mg group showed improvements in gait speed and lower-extremity function. Again, no skin biopsies or collagen assays were performed, but the dose-response relationship for systemic NAD+ augmentation was clarified [Igarashi 2022].

Irie et al. (2020) provided earlier pharmacokinetic data in healthy Japanese men, showing that single oral doses of 100 mg, 250 mg, and 500 mg NMN were well tolerated and dose-dependently increased plasma NMN and NAD+ metabolites. This safety and pharmacokinetic groundwork supports the feasibility of sustained dosing for any potential skin application [Irie 2020].

Liao et al. (2021) tested NMN in amateur runners at 300 mg, 600 mg, and 1200 mg daily for 6 weeks. Aerobic capacity improved in a dose-dependent manner. The highest dose showed the greatest effect, suggesting that even relatively high NMN doses are safe and bioactive in humans. No dermatological outcomes were assessed [Liao 2021].

Niu et al. (2023) examined short-term NMN supplementation (300 mg daily for 8 weeks) in middle-aged adults. They reported changes in serum metabolic profiles, fecal microbiota composition, and telomere length in peripheral blood mononuclear cells. Telomere length is not collagen, but the study adds to the evidence that NMN produces measurable systemic biological effects beyond NAD+ elevation alone [Niu 2023].

Study	Design	Population	NMN Dose	Duration	Primary Outcome	Skin/Collagen Data
Yoshino 2021	RCT, crossover	25 prediabetic women	250 mg/day	10 weeks	Muscle insulin sensitivity	None
Igarashi 2022	RCT, parallel	42 healthy older men	250 or 500 mg/day	12 weeks	Muscle function, NAD+ levels	None
Irie 2020	Single-/multiple-dose PK	10 healthy men	100–500 mg/day	5–12 weeks	Safety, metabolite levels	None
Liao 2021	RCT, parallel	48 amateur runners	300–1200 mg/day	6 weeks	Aerobic capacity	None
Niu 2023	RCT, parallel	8 middle-aged adults	300 mg/day	8 weeks	Metabolomics, telomere length	None

The table above makes one point unmistakably clear: human RCTs of NMN have not yet examined collagen synthesis, skin elasticity, wrinkle depth, or any dermatological endpoint. Any claim that NMN directly increases skin collagen in humans is extrapolation, not evidence. The honest takeaway is that NMN reliably raises NAD+ in people, and NAD+ is biochemically necessary for collagen production — but the bridge between those two facts has not been built in clinical trials.

The Mechanism

Why Collagen Synthesis Demands NAD+

Collagen is the most abundant protein in the human body, and its production is metabolically expensive. Fibroblasts in the dermis synthesize procollagen chains that undergo extensive post-translational modification before becoming mature, cross-linked collagen fibrils. Two of these modifications — proline and lysine hydroxylation — are absolutely dependent on molecular oxygen and reducing equivalents. The enzymes that perform these hydroxylations, prolyl hydroxylase and lysyl hydroxylase, require α-ketoglutarate as a cosubstrate and ascorbate (vitamin C) as a cofactor. Critically, they also depend on a maintained NAD+/NADH ratio for optimal function within the mitochondrial and cytosolic redox environment.

More fundamentally, collagen synthesis requires ATP. A single collagen molecule contains over 1,000 amino acids, and the secretory pathway trafficking of procollagen from the endoplasmic reticulum through the Golgi consumes substantial cellular energy. Fibroblasts from aged skin show reduced mitochondrial ATP production, and this energetic deficit correlates with decreased collagen synthesis in vitro. NAD+ is the central coenzyme for oxidative phosphorylation; without adequate NAD+, ATP generation falters, and energetically demanding biosynthetic processes like collagen production are among the first to be downregulated.

NAD+ Decline With Age

Gomes et al. (2013) demonstrated in a series of mouse experiments that NAD+ levels decline with age in multiple tissues, including skin. This decline was linked to increased activity of NAD+-consuming enzymes, particularly CD38, and to a pseudohypoxic state that disrupted nuclear-mitochondrial communication. Restoring NAD+ levels in aged mice, through either NMN or nicotinamide riboside supplementation, reversed markers of this pseudohypoxic signaling and improved mitochondrial function [Gomes 2013].

The relevance to collagen is indirect but mechanistically coherent. If NAD+ decline impairs mitochondrial ATP production, and if collagen synthesis requires abundant ATP, then NAD+ depletion would logically constrain collagen production. Restoring NAD+ via NMN precursor supplementation could, in principle, relieve this energetic bottleneck. However, Gomes et al. (2013) did not measure skin collagen in their murine experiments, and murine skin biology differs substantially from human skin in terms of thickness, UV exposure patterns, and aging trajectory. The mechanism is plausible; the human translation is unproven.

The Sirtuin Connection

NAD+ also serves as the obligate substrate for sirtuins, a family of NAD+-dependent deacetylases that regulate cellular stress responses, DNA repair, and mitochondrial biogenesis. SIRT1, in particular, has been implicated in the regulation of transforming growth factor-β (TGF-β) signaling, a pathway that stimulates collagen transcription in fibroblasts. In cell culture models, SIRT1 activation has been associated with increased type I collagen expression, though the literature is mixed and some contexts show SIRT1-mediated suppression of collagen in fibrotic conditions. The relationship is context-dependent, and no human NMN trial has measured sirtuin activity in skin fibroblasts.

What the Evidence Doesn't Show

It is worth being explicit about the gaps, because supplement marketing often fills them with confident assertions that the scientific literature does not support.

First, no human study has demonstrated that oral NMN increases skin collagen content, improves skin elasticity, reduces wrinkle depth, or enhances any dermatological outcome measured by standardized instruments. The studies by Yoshino et al. (2021), Igarashi et al. (2022), and others were not designed to answer skin questions, and their endpoints provide no proxy for dermal collagen.

Second, the optimal NMN dose for any potential skin benefit is unknown. The doses used in human trials range from 250 mg to 1,200 mg daily, with 250–500 mg being the most commonly studied range. Whether skin fibroblasts require higher or lower NAD+ elevation than skeletal muscle or cardiac tissue is entirely speculative. For readers considering a specific product, Bio:sudo NMN 1000mg provides a dose at the upper end of the studied range, though no trial has tested this exact formulation for skin outcomes.

Third, the bioavailability of NMN to dermal fibroblasts after oral administration is unclear. NMN is absorbed from the gut and appears in plasma, but whether it reaches skin tissue in concentrations sufficient to alter fibroblast NAD+ metabolism has not been directly measured in humans. NAD+ itself does not cross cell membranes efficiently, which is why precursor strategies (NMN, nicotinamide riboside) are used, but tissue distribution patterns vary by precursor and by tissue type.

Fourth, collagen synthesis is regulated by multiple inputs beyond cellular energy status. Mechanical stimulation, TGF-β signaling, ascorbate availability, and hormonal status (particularly estrogen) all play major roles. NMN, even if it successfully raises fibroblast NAD+, would be one variable among many. It is unlikely to overcome collagen loss driven by UV photodamage, smoking, or severe nutritional deficiency.

Who Benefits Most

Given the current evidence, the most defensible candidates for NMN supplementation with skin health as a secondary consideration are:

Middle-aged and older adults with declining NAD+ status. The human trials by Igarashi et al. (2022) and Yoshino et al. (2021) focused on this demographic and showed consistent NAD+ elevation. If the mechanistic link between NAD+ and collagen synthesis holds in humans, this population has the most to gain because they experience the steepest age-related NAD+ decline.

Individuals already optimizing other collagen-supporting factors. NMN should not be viewed as a replacement for adequate protein intake, vitamin C, or sun protection. It makes the most sense as a complementary strategy for people who have those bases covered and are looking to address the cellular energy dimension of skin aging. Those interested in a broader approach might also review supplements for hair, skin & nails to understand how different nutrients contribute to dermatological health.

People prioritizing systemic metabolic health alongside skin goals. Yoshino et al. (2021) demonstrated improved muscle insulin sensitivity with NMN. For individuals with prediabetes or early insulin resistance, the metabolic benefits are better supported than any dermatological claim, and potential skin effects would be a secondary consideration.

Not recommended: Young adults with normal NAD+ metabolism have no evidence-based reason to take NMN for skin health. The cost-benefit calculus is unfavorable when baseline collagen synthesis is already robust and NAD+ levels are near their lifetime peak.

Practical Takeaways

• NMN raises NAD+ in humans consistently. This is established across multiple RCTs. It is not theoretical.
• Collagen synthesis requires NAD+-dependent energy production. The biochemical logic is sound, but human skin-specific proof is absent.
• Doses of 250–500 mg/day have the strongest safety data. Higher doses up to 1,200 mg appear safe but have less long-term tracking. Bio:sudo NMN 1000mg falls within the studied range.
• Do not abandon proven collagen-supporting practices. Sun protection, adequate protein, vitamin C, and topical retinoids have far more evidence for skin structure preservation than any oral NAD+ precursor.
• Consider NMN as a systemic metabolic supplement with theoretical skin benefits, not as a targeted skin treatment. For a deeper look at the skin-specific discussion, see NMN for skin health.
• Monitor your expectations. If you choose to try NMN for skin, meaningful structural changes would take months to become visible, given the slow turnover of dermal collagen.

Bottom Line

The case for NMN and Collagen production rests on solid biochemistry and incomplete clinical evidence. NAD+ is essential for the ATP-dependent process of collagen synthesis, and NMN reliably restores NAD+ in human tissues. However, no published human trial has measured whether NMN supplementation increases skin collagen, improves elasticity, or reduces wrinkles. The mechanism is plausible, the safety profile at studied doses is favorable, but the skin-specific claims remain extrapolation. For those interested in collagen supplementation specifically, the collagen supplements evidence page covers the direct approach with a different evidence base.

References

1. Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224–1229. [Source]
2. Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging. 2022;8(1):5. [Source]
3. Irie J, et al. "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. 2020;67(2):153–160. [Source]
4. Liao B, et al. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study." Journal of the International Society of Sports Nutrition. 2021;18(1):54. [Source]
5. Gomes AP, et al. "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging." Cell. 2013;155(7):1624–1638. [Source]
6. Niu KM, et al. "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase." Nutrients. 2023;15(3):755. [Source]

---

---